Bruno Julianne bought CRSP
February 18, 2025 · Form 4 insider transaction
Bruno Julianne bought 650 shares of CRISPR Therapeutics AG, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
650
Price
N/A
Total value
N/A
InsiderBruno Julianne
RoleOfficer, Director
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateFebruary 18, 2025
Filing dateFebruary 19, 2025
Shares owned after7,395
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.